Not exact matches
Results from the
study, said its principal
investigator Dr Meenakshi Choudhary, from the Newcastle Fertility Centre at Life, Newcastle upon Tyne, United Kingdom, reaffirm the observation that a couple's fertility appears significantly more dependent on the age of the female partner than on that of the male.
Dr Florent Ginhoux, senior principal
investigator at SIgN and lead scientist of the
study, said previous research had examined thousands of cells at once.
«We found that nearly one in four patients with small tumours are at risk of distant metastases and do benefit from chemotherapy,» said
Dr Fatima Cardoso, senior author of the
study, Co-Principal
Investigator of MINDACT and Director of the Breast Unit of the Champalimaud Clinical Centre, Lisbon, Portugal.
The
study's principal
investigator,
Dr Riccardo Marioni, from The University of Edinburgh's Centre for Genomic and Experimental Medicine, said: «We are still a long way from making an accurate prediction for an individual's hair loss pattern.
Dr Sian Clarke from the London School of Hygiene & Tropical Medicine, also a principal
investigator in the research, said: «This
study shows that rapid diagnostic tests can improve the use of artemisinin - based combination therapies — the most effective treatment for malaria — in drug shops, but it's not without its challenges.
We are grateful to NMRC for their support in this
study,» said
Dr Joanne Ngeow, Co-Principal
Investigator of this
study and Senior Consultant Medical Oncologist, National Cancer Centre Singapore.
One of the
study's clinical
investigators,
Dr Eric Widra from Shady Grove Fertility in Washington DC, USA, acknowledged that interest in a freeze - all approach to IVF is growing, but not yet with broad application.
According to
Dr Won Park, Inha University Hospital, Korea, and lead
investigator of the PLANETAS
study, «the challenge for biosimilars is to demonstrate similarity in therapeutic effectiveness, safety and immunogenicity to their reference product, not just biochemical and pharmacokinetic equivalence.»
Dr Brian Bigger, Chief Scientific
Investigator for the
study from The University of Manchester said: «It is fantastic to see a treatment we developed at The University of Manchester, in collaboration with clinicians, reach the point where we can test its effectiveness in patients.
IMB Senior Principal
Investigator Dr Bruno Reversade, one of the
study's authors, who also led the discovery of Elabela two years ago, stated, «I am very pleased that we have further uncovered a critical role of Elabela in the establishment of the circulatory system, following its discovery as a hormone essential for heart development in 2013.
The Principal
Investigator of the
study,
Dr Felix Eigenbrod, Associate Professor (Spatial Ecology) at the University of Southampton's Centre for Biological Sciences, says: «The growing geographic disconnect between energy demand, the extraction and processing of resources, and the environmental impacts associated with energy production activities makes it crucial to factor global trade into sustainability assessments.
Dr Valerie Voon, principal
investigator of the
study, says: «Seemingly diverse choices — drug taking, eating quickly despite weight gain, and compulsive cleaning or checking — have an underlying common thread: rather that a person making a choice based on what they think will happen, their choice is automatic or habitual.
Dr Margaret O'Hara, from the Molecular Physics Group and primary
investigator on the project, said: «Previous
studies have found potential biomarkers for liver disease, such as isoprene and acetone, but they are not specific enough because they are possible biomarkers for other diseases or can arise from numerous normal metabolic processes.
«Systemic treatment for hepatocellular carcinoma has long consisted of just one agent — sorafenib - which was shown to provide a significant improvement in life expectancy almost 10 years ago, but no other agent has surpassed its benefits,» said the
study's principal
investigator Dr Jordi Bruix, Head of the BCLC group at the Hospital Clínic and Scientific Director of the Network for Biomedical Research for Hepatic and Digestive Diseases (CIBEREHD).
Investigator Dr Noor Danhof from the AMC Centre for Reproductive Medicine in Amsterdam says the results of the
study, a large randomised trial performed in the Netherlands, now make this «least expensive and least invasive stimulation agent» the drug of choice in IUI.
In the current
study, we demonstrate that the same agent prevents oedema in mice,» says
Dr Thomas Renné at the Department of Molecular Medicine and Surgery, Karolinska Institutet, principal
investigator of the
study.
Dr Christoffer Rahm is the initiator and the principal
investigator of this treatment
study.
Dr Jennifer Buckingham is Senior Research Fellow at The Centre for Independent
Studies, Director of the FIVE from FIVE reading project, and Associate
Investigator at the ARC Centre of Excellence for Cognition and Its Disorders.
Educational Experiences and Outcomes for Children with Special Educational Needs: A Secondary Analysis of Data from the Growing Up in Ireland
Study Principal
Investigator:
Dr Jude Cosgrove, Educational Research Centre.
Some groundbreaking findings from this
study appear in a recent paper in PLoS Genetics, «Genome - wide Association Study Identifies Shared Risk Loci Common to Two Malignancies in Golden Retrievers» (http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1004922) From work performed in Dr Lindblad - Toh's lab, the investigators report that they have identified two loci that together contribute approximately 20 % of the risk of developing hemangiosarcoma and lymphoma in Gol
study appear in a recent paper in PLoS Genetics, «Genome - wide Association
Study Identifies Shared Risk Loci Common to Two Malignancies in Golden Retrievers» (http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1004922) From work performed in Dr Lindblad - Toh's lab, the investigators report that they have identified two loci that together contribute approximately 20 % of the risk of developing hemangiosarcoma and lymphoma in Gol
Study Identifies Shared Risk Loci Common to Two Malignancies in Golden Retrievers» (http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1004922) From work performed in
Dr Lindblad - Toh's lab, the
investigators report that they have identified two loci that together contribute approximately 20 % of the risk of developing hemangiosarcoma and lymphoma in Goldens.
Dr Michael A Harkey, the chief
investigator, did a similar
study in Great Danes with exciting results.
Author Contributions: As principal
investigators,
Drs Raine and Harper had full access to all of the data in the
study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Funding / Support: This
study was supported by grants R01MH063852 (
Dr Weissman, principal
investigator) and N01 MH90003 (
Dr Rush, principal
investigator) from the National Institute of Mental Health.
Data sharing statement Additional unpublished data are available by contacting the Vancouver At Home
Study Principal
Investigator,
Dr Julian Somers at
[email protected].
Dr Wisner is the lead
investigator of largest
study of MMH disorders in the US and founder of the North American Perinatal Maternal Mental Health Society, bringing together researchers and thought leaders in MMH.